Pyrazolopyrimidines and related heterocycles as CK2 inhibitors
US9303033B2 · kind B2 · utility
6Cited by
1References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2013 |
| Grant date | Apr 5, 2016 |
| Priority date | — |
| Expiry date | Sep 13, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds that inhibit protein kinase CK2 activity (CK2 activity), and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and have the following general formula:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.